Medicine & Health

A team led by Washington University in St. Louis has been awarded $1 million over two years from the National Science Foundation’s Regional Innovation Engines program to help advance neuroscience technologies.

The School of Medicine has received two grants totaling $22.5 million to help lead national efforts to understand how DNA changes create differences in genomes across tissues within the same person.

Researchers have published a new set of reference human genome sequences that reveals far more genomic diversity from different populations of people than was available previously. The School of Medicine serves as the national coordinating center for the program, called the Human Pangenome Reference Consortium.

Ophthalmology and health-equity advocacy have uncovered a third passion for Alexandra Zdonczyk: St. Louis. In July, Zdonczyk will begin her residency in ophthalmology at Barnes-Jewish Hospital.

Scientists at the Center for Clinical Pharmacology have identified a potential pathway to pain relief that neither triggers addiction nor causes hallucinations.

Pamela K. Woodard, MD, a national leader in cardiothoracic imaging, has been named head of the Department of Radiology, director of the Mallinckrodt Institute of Radiology and the Elizabeth E. Mallinckrodt Professor of Radiology at the School of Medicine.

Dayna S. Early, MD, a professor at the School of Medicine, will receive the 2023 Distinguished Endoscopic Research Mentoring Award from the American Society for Gastrointestinal Endoscopy.

The pre-nursing program at University College gives School of Medicine employees and other working adults the academic foundation to enter a bachelor’s of nursing program. The program is flexible, feasible and for most university employees, free. 

Patrick White, MD, PhD, director of the Division of Palliative Medicine in the Department of Medicine at the School of Medicine, has been selected to receive the 2023 Josefina B. Magno Distinguished Hospice Physician Award from the American Academy of Hospice and Palliative Medicine.

A new drug has been approved by the Food and Drug Administration (FDA) for a rare, inherited form of amyotrophic lateral sclerosis (ALS). The drug — based in part on research conducted at the School of Medicine — slows the progression of the deadly, paralyzing disease.